According to preliminary results, about 90 percent of the votes cast were in favor of the merger agreement, Cigna said. The final voting results will be filed with Securities and Exchange Commission.
“Our combined company will enhance Cigna’s differentiated service-based model, fueled by actionable insights and analytics, to drive innovation and meaningful growth in a highly dynamic market environment,” said David M. Cordani, president and CEO of Cigna. “As a result, we will build more effective partnerships, further improve health outcomes and deliver a superior customer experience.”
The Department of Justice is still conducting an antitrust review of the transaction that is not expected to close until later this year, according to Reuters. Cigna expects the deal to close by the end of 2018.
In March 2018, Cigna agreed to acquire Express Scripts in a cash and stock transaction valued at about $67 billion, including Cigna’s assumption of $15 billion in Express Scripts debt.
More articles on payers:
Medicaid work requirements put nearly 13K Arkansas beneficiaries at risk of losing coverage
Anthem not complying with Medicare payment investigation, feds say
Blue Shield of California erroneously cancels coverage for undisclosed number of members
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
